The Utility of SOX2 and AGR2 Biomarkers as Early Predictors of Tamoxifen Resistance in ER-Positive Breast Cancer Patients.

Yomna A ZamzamYosra Abdelmonem ZamzamMarwa AboalsoudHeba Harras

Published in: International journal of surgical oncology (2021)

Integrated use of SOX2 and AGR2 biomarkers with serum AGR2 assay holds a promising hope for their future use as predictive markers for early detection of tamoxifen resistance in ER-positive breast cancer patients.

Keyphrases

estrogen receptor
breast cancer cells
transcription factor
stem cells
positive breast cancer
endoplasmic reticulum
high throughput
current status
single cell